Skip to main content
. 2008;119:217–224.

TABLE 1.

Phenotypic characterizations and lipid profiles of apoB38.9-bearing congenic strains1,2

Strain N Liver TG mg/gm Liver CHOL mg/gm Serum TG mg/dL Serum CHOL mg/dL
Female
    BALB-apoB+/+ 38 123 (44)bC 13.1 (1.7)bC 86 (27)A 61 (15)aA
    BALB-apoB+/38.9 55 243 (57)aA 16.4 (2.7)aA 88 (33)A 42 (14)bC
    C57-apoB+/+ 39 79 (26)bD 14.4 (2.3)bBC 56 (20)B 64 (12)aA
    C57-apoB+/38.9 49 157 (29)aB 16.3 (2.4)aA 61 (28)B 50 (10)bBC
    SWR-apoB+/+ 12 46 (23)bE 14.3 (1.5)bBC 97 (29)A 56 (10)aAB
    SWR-apoB+/38.9 21 101 (29)aCD 15.7 (2.2)aAB 90 (29)A 32 (14)bD
Male
    BALB-apoB+/+ 23 132 (41)bBC 13.2 (1.5)BC 106 (30)A 85 (21)aA
    BALB-apoB+/38.9 49 287 (130)aA 14.7 (2.6)AB 93 (38)AB 66 (23)bB
    C57-apoB+/+ 41 74 (28)bCD 12.6 (2.0)C 74 (23)B 74 (15)AB
    C57-apoB+/38.9 24 151 (44)aB 13.9 (2.1)ABC 76 (20)B 71 (9)AB
    SWR-apoB+/+ 10 36 (14)bD 14.2 (1.7)ABC 84 (18)AB 68 (21)AB
    SWR-apoB+/38.9 12 62 (27)aD 15.2 (1.3)A 89 (19)AB 60 (8)B

1 Plasma and hepatic lipids were assessed using commercial methods described in 10. Liver triglyceride and cholesterol were expressed as mg/g liver protein. Results are means (SD).

2 The low-case superscript in each column (a and b) indicated significant difference (α = 0.01) between apoB genotype (apoB+/+ vs apoB+/38.9) within each genetic background (BALB, C57, or SWR). The upper-case superscript in each column (A, B etc) indicated the results of multiple comparisons among means of all congenics (Duncan's multiple range test, α = 0.01).